Pentachlorophenol (but not phenobarbital) promotes intrahepatic biliary cysts induced by diethylnitrosamine to cholangio cystic neoplasms in B6C3F1 mice possibly due to oxidative stress.
Administration of diethylnitrosamine (DEN) to B6C3F1 mice at low dose (20 ppm) in drinking water for long duration resulted in formation of multifocal cystic biliary lesions in the liver. To investigate the potential of the lesions to be promoted to neoplasias by chemicals, we examined the effects of 2 different types of hepatocarcinogenesis promoters, pentachlorophenol (PCP) and phenobarbital (PB) in B6C3F1 mice. Two weeks' exposure to PCP at a concentration of 600 ppm in the diet increased 8-oxodeoxyguanosine (8-oxodG) levels in liver nuclear DNA, and cell proliferation quantified by bromodeoxyuridine (BrdU) incorporation in epithelial cells of intrahepatic bile ducts as well as hepatocytes. In mice initiated with DEN at 20 ppm in the drinking water for the first 13 weeks followed, after a 4-week recovery interval, by PCP at a concentration of 600 ppm in the diet for 25 weeks, cystic atypical hyperplasias, cholangiomas, and cholangiocarcinomas were present at statistically significant higher incidences. In contrast, neoplasia did not occur in animals treated with 500 ppm PB, and there were no elevations in 8-oxodG levels or increases in the proliferation of biliary epithelium, although proliferation was increased in hepatocytes. These findings suggest that oxidative stress due to PCP might exert a promoting action on the biliary cystic lesions produced by DEN.
Umemura
Takashi
T
Division of Pathology, Biological Safety Research Center, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan, umemura@nihs.go.jp
Kodama
Yukio
Y
Kanki
Keita
K
Iatropoulos
Michael J
MJ
Nishikawa
Akiyoshi
A
Hirose
Masao
M
Williams
Gary M
GM
D000080242:8-Hydroxy-2'-Deoxyguanosine; D000818:Animals; D001649:Bile Duct Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D001650:Bile Duct Neoplasms / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D001653:Bile Ducts, Intrahepatic / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D002273:Carcinogens / Q000633:toxicity*; D002455:Cell Division / Q000187:drug effects; D018281:Cholangiocarcinoma / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D003043:Cocarcinogenesis; D003560:Cysts / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D004247:DNA / Q000096:biosynthesis; D003849:Deoxyguanosine / Q000031:analogs & derivatives* / Q000032:analysis; D004052:Diethylnitrosamine / Q000633:toxicity; D004847:Epithelial Cells / Q000187:drug effects; D022781:Hepatocytes / Q000187:drug effects; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D018384:Oxidative Stress / Q000187:drug effects*; D010416:Pentachlorophenol / Q000633:toxicity; D010634:Phenobarbital / Q000633:toxicity
D002273:Carcinogens; D004052:Diethylnitrosamine; D000080242:8-Hydroxy-2'-Deoxyguanosine; D004247:DNA; D010416:Pentachlorophenol; D003849:Deoxyguanosine; D010634:Phenobarbital